The move follows the agency’s warning to the company over the repeated violations of cGMPs (current good manufacturing practices) and the Federal Food, Drug and Cosmetic Act.
In 2010, FDA inspection found that Kabco distributed supplements that did not meet product specifications.
The company also failed to investigate product complaints and hold dietary supplements under conditions designed to prevent product mix-ups, according to the agency.
FDA wants Kabco to comply with the Federal Food, Drug and Cosmetic Act and cGMPs before the company restarts its operations.
Kabco Pharmaceuticals dietary supplements include Brewers Yeast Tablets, Dandelion Root Capsules and Night-Time Herb Capsules.
The other products include Inositol Calcium and Magnesium Capsules, Vitamin C-500 with Rose Hips Time Released Tablets and Joint All Capsules.